miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase

British Journal of Cancer, Published online: 18 May 2020; doi:10.1038/s41416-020-0884-9miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase

Source: British Journal of Cancer - May 17, 2020 Category: Cancer & Oncology Authors: Francesca Maria Orlandella Raffaela Mariarosaria Mariniello Peppino Mirabelli Anna Elisa De Stefano Paola Lucia Chiara Iervolino Vito Alessandro Lasorsa Mario Capasso Rosa Giannatiempo Maria Rongo Mariarosaria Incoronato Francesco Messina Marco Salvatore Source Type: research